NicOx SA (COX):企業の財務・戦略的SWOT分析

◆英語タイトル:NicOx SA (COX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14850
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NicOx SA (NicOx) is an ophthalmology company that develops solutions to help maintain vision and improve ocular health. The company’s products include Vyzulta, a latanoprostene bunod ophthalmic solution; and Zerviate, a cetirizine ophthalmic solution. It offers products in the therapeutic areas of glaucoma, conjuctivitis and blepharitis based on a strong research platform which creates new molecular entities. NicOx operates research centers in Italy that conducts studies covering various therapeutic areas such as cardiovascular, inflammation and ophthalmology. The company has operations in Germany, the UK, France, Italy and the US. It collaborates with universities and research institutions. NicOx is headquartered in Valbonne, France.

NicOx SA Key Recent Developments

Mar 06,2019: Nicox announces 2018 financial results and 2019 milestones
Jan 28,2019: Nicox establishes high-profile glaucoma clinical advisory board
Jan 17,2019: Nicox announces fourth quarter 2018 business update and financial highlights
Dec 17,2018: Nicox and Ocumension partner to develop and commercialise glaucoma drug
Oct 17,2018: Nicox Third Quarter 2018 Business Update and Financial Highlights

This comprehensive SWOT profile of NicOx SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NicOx SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

NicOx SA – Key Information
NicOx SA – Overview
NicOx SA – Key Employees
NicOx SA – Key Employee Biographies
NicOx SA – Key Operational Heads
NicOx SA – Major Products and Services
NicOx SA – History
NicOx SA – Company Statement
NicOx SA – Locations And Subsidiaries
NicOx SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

NicOx SA – Business Description
NicOx SA – Corporate Strategy
NicOx SA – SWOT Analysis
SWOT Analysis – Overview
NicOx SA – Strengths
NicOx SA – Weaknesses
NicOx SA – Opportunities
NicOx SA – Threats
NicOx SA – Key Competitors

Section 3 – Company Financial Performance Charts

NicOx SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

NicOx SA, Key Information
NicOx SA, Key Ratios
NicOx SA, Share Data
NicOx SA, Major Products and Services
NicOx SA, History
NicOx SA, Key Employees
NicOx SA, Key Employee Biographies
NicOx SA, Key Operational Heads
NicOx SA, Other Locations
NicOx SA, Subsidiaries
NicOx SA, Key Manufacturing facilities
NicOx SA, Key Competitors
NicOx SA, SWOT Analysis
NicOx SA, Ratios based on current share price
NicOx SA, Annual Ratios
NicOx SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

NicOx SA, Performance Chart
NicOx SA, Ratio Charts

★海外企業調査レポート[NicOx SA (COX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • Genentech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • Actuated Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Actuated Medical Inc (Actuated Medical) is a medical device company that develops minimally invasive instruments. The company provides products such as controlled tissue penetration systems, occlusion clearing systems and MRI compatible systems. Its controlled tissue penetration systems use …
  • Aeris Resources Limited:企業の戦略・SWOT・財務情報
    Aeris Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Aeris Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NextEra Energy, Inc.:企業の戦略・SWOT・財務情報
    NextEra Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary NextEra Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GenSight Biologics SA (SIGHT):製薬・医療:M&Aディール及び事業提携情報
    Summary GenSight Biologics SA (GenSight) is a clinical stage biotechnology company that discovers and develops novel therapies for mitochondrial and neurodegenerative diseases. The company’s product pipeline comprises GS010 and GS030 developed for the treatment of retinal degenerative diseases. It d …
  • Sartorius AG (SRT):医療機器:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Eiger BioPharmaceuticals Inc (EIGR):企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • Energate Inc:企業の戦略的SWOT分析
    Energate Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Turner & Townsend Plc:企業の戦略的SWOT分析
    Turner & Townsend Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Adcock Ingram Holdings Ltd (AIP):企業の財務・戦略的SWOT分析
    Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Saudi Industrial Investment Group (2250):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Investment Group (SIIG) is a petrochemical company that invests, improves and develops petrochemical industry. The company produces cyclohexane, benzene, ethylene, polyethylene, hexane, polypropylene and polystyrene. It also provides propylene, styrene, motor gasoline blend, …
  • Hunter Oil Corp (HOC):企業の財務・戦略的SWOT分析
    Summary Hunter Oil Corp (HOC), formerly Enhanced Oil Resources Inc is an oil and gas company that offers energy production programs. The company offers production and rehabilitation of its legacy oil fields through full cycle development. It also provides full cycle development services such as rese …
  • Sharp Corporation:企業の戦略・SWOT・財務情報
    Sharp Corporation - Strategy, SWOT and Corporate Finance Report Summary Sharp Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Reinsurance Group of America, Incorporated:戦略・SWOT・企業財務分析
    Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Dominion Energy Inc (D):電力:M&Aディール及び事業提携情報
    Summary Dominion Energy, Inc. (Dominion), formerly Dominion Resources, Inc., is a producer and transporter of energy. It carries out the generation, transmission and distribution of electricity; transmission, distribution, storage and processing of gas; and LNG import and storage activities. The com …
  • Olink Proteomics AB:医療機器:M&Aディール及び事業提携情報
    Summary Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. …
  • Fairfield Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Fairfield Energy Ltd (Fairfield Energy), a subsidiary of Decom Energy Ltd is an oil and gas company that offers oil and gas decommissioning services. The company acquires and develops hydrocarbon properties. It acquires and operates marginal fields in the UK continental shelf. Fairfield Ener …
  • Ariel Corp:企業の戦略的SWOT分析
    Ariel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆